SLN Silence Therapeutics Plc

held by 1 manager in Q3 2024

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.25%	9 mo	—	$7M	387,400

Search